Myofiber degeneration/regeneration is induced in the cachectic Apc Min/+ mouse

Journal of Applied Physiology

Volumn 99, Issue 6, 2005, Pages 2379-2387

  Mehl, Kristeil A ^a   Davis, J Mark ^a   Berger, Franklin G ^a   Carson, James A ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Colon cancer; Inflammatory cytokines; Muscle wasting

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 6; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; COLON CANCER; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROCNEMIUS MUSCLE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEG MUSCLE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE REGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; SKELETAL MUSCLE; SOLEUS MUSCLE; WESTERN BLOTTING;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; CACHEXIA; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENES, APC; MICE; MICE, INBRED C57BL; MUSCLE FIBERS; MUSCLE, SKELETAL; REGENERATION;

EID: 28044448490     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00778.2005     Document Type: Article

References (49)

1. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, and Guttridge DC. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114: 370-378, 2004.
2. Aebi H. Catalase in vitro. Methods Enzymol 105: 121-126, 1984.
3. Agbulut O, Noirez P, Beaumont F, and Butler-Browne G. Myosin heavy chain isoforms in postnatal muscle development of mice. Biol Cell 95: 399-406, 2003.
4. Ardies CM. Exercise, cachexia, and cancer therapy: a molecular rationale. Nutr Cancer 42: 143-157, 2002.
5. Argiles JM, Busquets S, and Lopez-Soriano FJ. Cytokines in the pathogenesis of cancer cachexia. Curr Opin Clin Nutr Metab Care 6: 401-406, 2003.
6. Barton BE and Murphy TF. Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen. Cytokine 16: 251-257, 2001.
7. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, and Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
9. Buck M and Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15: 1753-1765, 1996.
10. Buck M, Houglum K, and Chojkier M. Tumor necrosis factor-alpha inhibits collagen alpha 1(1) gene expression and wound healing in a murine model of cachexia. Am J Pathol 149: 195-204, 1996.
11. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, and Shoelson SE. IKK/NF-κB activation causes severe muscle wasting in mice. Cell 119: 285-298, 2004.
12. Charge SB and Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238, 2004.
13. Corpet DE and Pierre F. Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 12: 391-400, 2003.
14. Davis TW, Zweifel BS, O'Neal JM, Heuvelman DM, Abegg AL, Hendrich TO, and Masferrer JL. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting. J Pharmacol Exp Ther 308: 929-934, 2004.
15. Diffee GM, Kalfas K, Al-Majid S, and McCarthy DO. Altered expression of skeletal muscle myosin isoforms in cancer cachexia. Am J Physiol Cell Physiol 283: C1376-C1382, 2002.
16. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
17. Elliott JL. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 95: 172-178, 2001.
18. Emery PW, Lovell L, and Rennie MJ. Protein synthesis measured in vivo in muscle and liver of cachectic tumor-bearing mice. Cancer Res 44: 2779-2784, 1984.
19. Finck BN and Johnson RW. Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1β in the rat. Brain Res 761: 333-337, 1997.
20. Fleck A and Munro HN. The precision of ultraviolet absorption measurements in the Schmidt-Thannhauser procedure for nucleic acid estimation. Biochim Biophys Acta 55: 571-583, 1962.
21. Giordano A, Calvani M, Petillo O, Carteni M, Melone MR, and Peluso G. Skeletal muscle metabolism in physiology and in cancer disease. J Cell Biochem 90: 170-186, 2003.
22. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600, 1991.
23. Haddad F, Zaldivar F, Copper DM, and Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 98: 911-917, 2005.
24. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 100: 57-70, 2000.
25. Holroyde CP, Skutches CL, Boden G, and Reichard GA. Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res 44: 5910-5913, 1984.
26. Hyltander A, Drott C, Korner U, Sandstrom R, and Lundholm K. Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 27: 9-15, 1991.
27. Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, Verbeken E, and Decramer M. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111: 996-1005, 2005.
28. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, and Glass DJ. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24: 9295-9304, 2004.
29. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, and Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51, 2004.
30. McCarthy DO, Whitney P, Hitt A, and Al-Majid S. Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma. Res Nurs Health 27: 174-184, 2004.
31. McClung JM, Lee WJ, Thompson RW, Lowe LL, and Carson JA. RhoA induction by functional overload and nandrolone decanoate administration in rat skeletal muscle. Pflügers Arch 447: 345-355, 2003.
32. Min/+ mice. J Appl Physiol 98: 2219-2225, 2005.
33. Ohba N, Maeda M, Sakamoto H, Kiyama H, Ishii M, Muraoka M, and Kaneda IC. Skeletal muscle regeneration associated with the stroma reaction during tumor invasion in the rat tongue. J Submicrosc Cytol Pathol 34: 367-376, 2002.
34. Perkins S, Clarke AR, Steward W, and Gescher A. Age-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcumin. Br J Cancer 88: 1480-1483, 2003.
35. Pizza FX, Peterson JM, Baas JH, and Koh TJ. Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice. J Physiol 562: 899-913, 2005.
36. Reid MB. Response of the ubiquhin-proteasome pathway to changes in muscle activity. Am J Physiol Regul Integr Comp Physiol 288: R1423-R1431, 2005.
37. Rigas B and Williams JL. NO-releasing NSAIDs and colon cancer chemoprevention: a promising novel approach (Review). Int J Oncol 20: 885-890, 2002.
38. Rubin H. Cancer cachexia: its correlations and causes. Proc Natl Acad Sci USA 100: 5384-5389, 2003.
39. Salvadori C, Peters IR, Day MJ, Engvall E, and Shelton GD. Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy. Muscle Nerve 31: 192-198, 2005.
40. Sass G, Heinlein S, Agli A, Bang R, Schumann J, and Tiegs G. Cytokine expression in three mouse models of experimental hepatitis. Cytokine 19: 115-120, 2002.
41. Smith HJ, Greenberg NA, and Tisdale MJ. Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice. Br J Cancer 91: 408-412, 2004.
42. Song YH, Li Y, Du J, Mitch WE, Rosenthal N, and Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 115: 451-458, 2005.
43. Strassmann G and Kambayashi T. Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy. Cytokines Mol Ther 1: 107-113, 1995.
44. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288: R345-R353, 2005.
45. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2: 862-871, 2002.
46. Tsujinaka T, Ebisui C, Fujita J, Kishibuchi M, Morimoto T, Ogawa A, Katsume A, Ohsugi Y, Kominami E, and Monden M. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun 207: 168-174, 1995.
47. Tucker JM, Davis C, Kitchens ME, Bunni MA, Priest DG, Spencer HT, and Berger FG. Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc(Min/+) mice. Cancer Lett 187: 153-162, 2002.
48. Yan Z, Choi S, Liu X, Zhang M, Schageman JJ, Lee SY, Hart R, Lin L, Thurmond FA, and Williams RS. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem 278: 8826-8836, 2003.
49. Zuijdgeest-van Leeuwen SD, van den Berg JW, Wattimena JL, van der Gaast A, Swart GR, Wilson JH, and Dagnelie PC. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism 49: 931-936, 2000.